Letter from the Editor EditorProf. Dennis McGonagle, University of Leeds, United Kingdom ConferenceEULAR 2018 24 August 2018 23:29
Early, intensive rheumatoid arthritis treatment seems to normalise mortality rates TrialCOBRA ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 23:36
Switching to biosimilar bDMARDs is safe and efficacious Presented ByProf. Kvien, University of Oslo and Diakonhjemmet Hospital, Norway TrialPhase 4, NOR-SWITCH ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 22:46
No significant differences when tapering TNF blockers versus csDMARDs Presented ByDr Van Mulligen, Erasmus MC, the Netherlands ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 21:51
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 20:26
Biologic drug levels and infection risk, and clinical effectiveness of sarilumab TrialTARGET ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 19:30
Confirmation of long-term safety profile adalimumab across indications Presented ByProf. Gerd Burmester, Charité University Hospital, Free University and Humboldt University of Berlin, Germany ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 18:39
Clinical effect of vedolizumab on articular manifestations spondyloarthritis associated with IBD Presented ByDr. Paccou, Amiens University Medical Center, France ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 23:43
Synergistic effect NSAIDs plus TNFi in slowing radiographic progression in ankylosing spondylitis patients Presented ByDr Gensler, University of California San Francisco Medical Center, USA ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 22:48
Low bone mineral density is common in axial spondyloarthritis; more awareness required TrialCohort study, axSpA ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 20:52
Osteoporosis and vertebral fractures associated with disease activity/radiographic damage in axial spondyloarthritis ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 23:38
Glucosepane is a new biomarker for the severity of osteoarthritis ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 22:40
miRNA-146A plays key role in bone metabolism and osteoporosis ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 21:42
Novel systemic sclerosis drugs: an overview of what might be to come TrialPhase 3, RESOLVE-1 ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 23:46
Promising results rituximab in systemic sclerosis, and systemic lupus erythematosus classification criteria Presented ByProf. Allanore, University of Paris Descartes University, France ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 22:49
Systemic lupus erythematosus: Baricitinib may be potential therapy, and clinical benefit of ustekinumab ConferenceEULAR 2018 TypePeer-reviewed article 24 August 2018 20:52